Page last updated: 2024-08-24

bimakalim and 1,3-dipropyl-8-cyclopentylxanthine

bimakalim has been researched along with 1,3-dipropyl-8-cyclopentylxanthine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gross, GJ; Grover, GJ; Mei, DA; Sleph, PG1

Other Studies

1 other study(ies) available for bimakalim and 1,3-dipropyl-8-cyclopentylxanthine

ArticleYear
Adenosine A1 receptor blockade does not abolish the cardioprotective effects of the adenosine triphosphate-sensitive potassium channel opener bimakalim.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 280, Issue:2

    Topics: Animals; Benzopyrans; Cardiotonic Agents; Coronary Circulation; Dihydropyridines; Dogs; Heart Rate; In Vitro Techniques; Ion Channel Gating; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Phenylisopropyladenosine; Potassium Channels; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Regression Analysis; Ventricular Function, Left; Xanthines

1997
chemdatabank.com